01 / FRONTIER
Cancer
Engineer immune cells to recognize what they once missed.
CELLULAR THERAPIES ↗
THE FUTURE OF GENOMIC INTELLIGENCE
What if the next cure
started with a question?
Genexome turns natural-language research hypotheses into clinically grounded, synthesis-ready CRISPR experiment designs — bringing genomic intelligence, evidence, design and validation into one private workspace.
PRIVATE BY DESIGNEVIDENCE GROUNDEDBUILT FOR CRISPR RESEARCH
GENEXOME / RESEARCH WORKSPACEHYPOTHESIS → DESIGN
✳ ASK GENEXOME
“Design a CRISPR strategy to investigate loss-of-function variants in PCSK9 associated with reduced LDL cholesterol.”
✓ TARGET IDENTIFIED→ EVIDENCE→ VARIANTS→ EDIT STRATEGY→ gRNA→ OFF-TARGETS→ CLINICAL CONTEXT→ SYNTHESIS
THE MOMENT WE'RE LIVING IN
The genome is becoming programmable.
Access to genomic intelligence should be too.
CRISPR has moved from an extraordinary laboratory technique into clinical medicine. Researchers are exploring its potential across inherited disease, cancer, cardiovascular disease and beyond. The next discoveries begin with the freedom to ask better questions.
02 / FRONTIER
Rare disease
Turn a pathogenic variant into an actionable research hypothesis.
PRECISION MEDICINE ↗
03 / FRONTIER
Cardiovascular disease
Explore genetic pathways that could reshape lifetime disease risk.
GENETIC TARGETS ↗
04 / FRONTIER
Inherited disorders
Investigate ways to address the biology beneath disease symptoms.
GENE CORRECTION ↗
This is the century in which biology becomes an engineering discipline.
THE FRICTION
The science moved forward.
The workflow didn’t.
A biological question becomes a scavenger hunt across databases, papers, sequence tools, clinical resources and one-off scripts.
Every context switch creates friction between the hypothesis in a scientist's mind and the experiment on the bench.
Genexome collapses that distance. ↗
PubMed ↗ClinVar ↗Ensembl ↗UCSC ↗CRISPick ↗Spreadsheets ↗Python ↗PDFs ↗Browser tabs ↗Local scripts ↗
INTRODUCING GENEXOME
From scientific intent to
experimental design.
One workspace.
Not just another guide RNA generator. A connected environment for the reasoning, evidence and design that surround every experiment.
GENEXOME / WORKSPACE / CONCEPT PREVIEW
01 / RESEARCH HYPOTHESIS
Investigate loss-of-function variants in PCSK9 associated with reduced LDL cholesterol.
MODENATURAL LANGUAGE
STATUSHYPOTHESIS CAPTURED
02 / GENOMIC INTELLIGENCE
GENEPCSK9
CONTEXTLIPID METABOLISM
EVIDENCEREVIEW REQUIRED
EDITING STRATEGYCANDIDATE ANALYSIS
SEQUENCE CONTEXT / ILLUSTRATIVE
ATGCTAGCCTGACTGGCTACGATCGTACCTGAGCTAGCTAGCATCG
03 / EXPERIMENT DESIGN
GUIDE CANDIDATESTO BE EVALUATED
OFF-TARGET REVIEWREQUIRED
CLINICAL CONTEXTLINKED EVIDENCE
EXPORTDESIGN PACKAGE
ILLUSTRATIVE UI — NOT A VALIDATED EXPERIMENT
01 / ASK
Start with the question
Describe a biological hypothesis in natural language.
02 / GROUND
Follow the evidence
Connect genes, variants, literature and clinical context.
03 / DESIGN
Explore strategies
Develop candidate editing approaches and guide designs.
04 / VALIDATE
Interrogate the risks
Review specificity, predicted off-targets and supporting evidence.
05 / EXPORT
Move toward the bench
Organize designs into synthesis-ready research specifications.
THE LIVING GENOME / INTERACTIVE JOURNEY
From sequence to possibility.
Every discovery begins with information. Explore how biological data becomes a question, a hypothesis, and a research plan.
GENOMIC SIGNAL / CONCEPT VISUALIZATION01 / 05
RAW SEQUENCE
Information is the beginning.
A sequence is more than letters. Its significance emerges through evidence, context and careful interpretation.
ILLUSTRATIVE VISUALIZATION · NOT GENOMIC ANALYSIS
EXPLORE THE EXPERIENCE
A scientific question.
A connected journey.
Try an interactive preview of the research workflow. This guided demonstration uses illustrative, prewritten scenarios—not live analysis or validated experimental outputs.
GENEXOME / GUIDED PRODUCT PREVIEWDEMONSTRATION MODE
01 / CHOOSE A RESEARCH QUESTION
Select a scenario to explore the conceptual workflow. No patient information or biological sequences are submitted.
02 / RESEARCH PATHWAY
READY TO EXPLORE
Your research journey starts here.
Choose a frontier and explore the steps connecting a hypothesis to an evidence-aware research plan.
03 / CONCEPT REPORT
RESEARCH CONTEXTNOT STARTED
SCIENTIFIC EVIDENCEREVIEW REQUIRED
DESIGN STATUSCONCEPT ONLY
SAFETY REVIEWREQUIRED
CLINICAL USENOT VALIDATED
RESEARCH NOTE
Outputs here are illustrative. Real experiments require primary-source review, validated analysis and specialist oversight.
THIS PREVIEW DOES NOT GENERATE GUIDE RNAS, VALIDATE OFF-TARGET EFFECTS, OR PRODUCE SYNTHESIS-READY DESIGNS.
A NEW WAY TO EXPLORE
Imagine having the genome at conversational distance.
01 ↗“Which pathogenic variants in this gene are theoretically addressable with base editing?”
02 ↗“Compare knockout and correction strategies for this disease mechanism.”
03 ↗“Show me clinically reported variants near this target.”
04 ↗“Design candidate guides and rank them by predicted specificity.”
05 ↗“What evidence supports this target?”
06 ↗“Turn this hypothesis into an experimental design.”
Don't learn the interface.
Ask the scientific question.
FOUR FRONTIERS / ONE HUMAN AMBITION
The possibilities are human.
Explore where genomic research may open new paths. Each frontier is an invitation to investigate—not a promise of a cure.
CELLULAR THERAPIES / RESEARCH FRONTIER
Reprogramming the defenders.
Engineered immune cells are reshaping cancer research. Genomic tools can help researchers explore how immune recognition, cell function and therapeutic design might be improved.
RESEARCH IS ONGOING · CLINICAL OUTCOMES VARY
01 / 04
HELP SHAPE WHAT COMES NEXT
The next chapter starts with researchers like you.
We’re building Genexome for people who believe scientific questions deserve better tools. Tell us what you work on and help shape the early experience.
✳ RESEARCHER-LED✳ PRIVATE BY DESIGN✳ ACCESSIBLE BY AMBITION
THE HUMAN REASON
Behind every variant
is a possibility.
A mechanism waiting to be understood.
A target waiting to be validated.
An experiment waiting to be designed.
A treatment that may not exist yet.
A target waiting to be validated.
An experiment waiting to be designed.
A treatment that may not exist yet.
Genexome exists to help researchers reach the experiment faster.
DEMOCRATISING GENOMIC INTELLIGENCE
Breakthrough tools shouldn't belong only to breakthrough budgets.
Genomic research shouldn't require an enterprise software stack, dedicated bioinformatics infrastructure and dozens of disconnected tools just to explore a hypothesis. We're building toward a private, secure, radically affordable workspace for scientific discovery.
↗
Accessible
Natural language lowers the computational barrier between scientific intent and genomic analysis.
◎
Integrated
Research, evidence, design and validation belong in one connected environment.
◇
Private
A workspace designed with sensitive scientific research and responsible data handling in mind.
Genomic intelligence for every researcher with a question worth asking.
THE HORIZON
The work of today.
The medicine of tomorrow.
01 / TODAY
Explore
Research → target discovery → experiment design.
02 / NEXT
Translate
Precision editing → personalized strategies → sophisticated therapeutic hypotheses.
03 / THE HORIZON
Reimagine
Medicine that understands disease closer to its molecular origin.
The future of medicine will be written in the language of biology.
Genexome is building the workspace to help researchers write it.
genexome.
A better question can start a better experiment.
A better experiment can change a life.
The end-to-end workspace for CRISPR research. Built for what comes next.
PRIVATE BY DESIGN · EVIDENCE GROUNDED · BUILT FOR CRISPR RESEARCH